Clinical trial
An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents…
NCT00122018 · Linda F. Barr, M.D., Other · Completed
Key facts
| NCT number | NCT00122018 |
|---|---|
| Title | An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery |
| Official title | N-acetylcysteine and Fenoldopam Protect the Renal Function of Patients With Chronic Renal Insufficiency Undergoing Cardiac Surgery. |
| Lead sponsor | Linda F. Barr, M.D., Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Failure, Acute, Chronic, Cardiac Surgical Procedures |
| Intervention type | Drug |
| Interventions | N-acetylcysteine, fenoldopam |
| Enrollment | 80 |
| Start date | May 1, 2002 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | Nov 7, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: